Vadimezan

CAS: 117570-53-3

Ref. TM-T6273

Produktinformation

• Name: Vadimezan
• Synonyme: DMXAA, 5,6-Dimethylxanthenone-4-acetic Acid, NSC 640488, ASA-404, (5,6-Dimethyl-9-Oxo-Xanthen)-4-Acetic Acid, (5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid, 2-(5,6-Dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid, 2-(5,6-Dimethyl-9-oxoxanthen-4-yl)acetic acid, 5,6-Dimethyl-9-oxo-9H-xanthen-4-ylacetic acid, 5,6-Dimethyl-9-oxo-9H-xanthene-4-acetic acid, 5,6-Dimethylxanthenone-4-acetic acid, 5,6-Dimethylxanthenoneacetic Acid, 9H-Xanthene-4-acetic acid, 5,6-dimethyl-9-oxo-, As 1404, Asa 404, D5817, Dmxaa, NSC 640488
• CAS: 117570-53-3

Beschreibung

Vadimezan (DMXAA) is a vascular disrupting agent, a murine STING agonist, and an inducer of cytokines such as type I IFN. Vadimezan has antitumor activity and induces a rapid cessation of blood flow in tumors without affecting blood flow in normal tissues.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 282.29
• Formel: C₁₇H₁₄O₄
• Reinheit: 99.8%
• Farbe/Form: Solid